Oct 15, 2012 15:00 BST Partnership to integrate Novalung’s membrane gas exchange technology into the Prismaflex platform adding CO2 removal to its therapeutic offering. Simple and reliable CO2 removal integrated in a well established blood purification platform is an unmet medical need in the ICU. It facilitates lung-protective ventilation allowing patients lungs to heal faster and reduce the length of stay in the ICU.
Image
Gambro-Novalung partnership
Oct 15, 2012 15:00 BST
Size:1.62 MB
Format:.jpg
Image dimensions:2592 x 1936 pixels
From left to right: Felix Dahm, Vice President Strategy & Business Development Gambro, Josef Bogenschütz, spokesman of Novalung’s Managing Board, Georg Matheis, Managing Director of Novalung, Guido Oelkers, President and CEO, Gambro, Stephan Aldinger, Vice President Acute Advanced Therapies, Global Marketing Acute, Gambro
